Diet-relevant phytochemical intake affects the cardiac AhR and nrf2 transcriptome and reduces heart failure in hypertensive rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1580-1586

  Seymour, E Mitchell ^a   Bennink, Maurice R ^b   Bolling, Steven F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b Michigan State University   (United States)

Author keywords

AhR; Antioxidant; Cardiac; Heart failure; Nrf2; Phytochemicals

Indexed keywords

ANTHOCYANIN; ANTIOXIDANT; CATECHIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; EPICATECHIN; FLAVONOL DERIVATIVE; GLUCURONOSYLTRANSFERASE 1A6; GLUTATHIONE; GLUTATHIONE PEROXIDASE 3; ISORHAMNETIN; KAEMPFEROL; MALVIDIN CHLORIDE; MESSENGER RNA; METALLOTHIONEIN I; METALLOTHIONEIN II; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONSENSUS SEQUENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC DYSFUNCTION; DIETARY INTAKE; DNA BINDING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRUIT; GLUTATHIONE METABOLISM; GRAPE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VEGETABLE;

RATTUS; VITACEAE;

EID: 84881555348     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.01.008     Document Type: Article

References (49)

1. Appel L.J., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336(16):1117-1124.
2. Levy D., et al. The progression from hypertension to congestive heart failure. JAMA 1996, 275(20):1557-1562.
3. Levitan E.B., Wolk A., Mittleman M.A. Consistency with the DASH diet and incidence of heart failure. Arch Intern Med 2009, 169(9):851-857.
4. Most M.M. Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet. J Am Diet Assoc 2004, 104(11):1725-1727.
5. Doyle L., Cashman K.D. The effect of nutrient profiles of the Dietary Approaches to Stop Hypertension (DASH) diets on blood pressure and bone metabolism and composition in normotensive and hypertensive rats. Br J Nutr 2003, 89(5):713-724.
6. Wu Q., Wang M., Simon J.E. Determination of proanthocyanidins in fresh grapes and grape products using liquid chromatography with mass spectrometric detection. Rapid Commun Mass Spectrom 2005, 19(14):2062-2068.
7. Seymour E.M., et al. Chronic intake of a phytochemical-enriched diet reduces cardiac fibrosis and diastolic dysfunction caused by prolonged salt-sensitive hypertension. J Gerontol A Biol Sci Med Sci 2008, 63(10):1034-1042.
8. Somova L.I., et al. Antioxidant status of the hypertrophic heart of Dahl hypertensive rat as a model for evaluation of antioxidants. Methods Find Exp Clin Pharmacol 2001, 23(1):5-12.
9. Huang K.P., Huang F.L. Glutathionylation of proteins by glutathione disulfide S-oxide. Biochem Pharmacol 2002, 64(5-6):1049-1056.
10. Thomas J.A., Poland B., Honzatko R. Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch Biochem Biophys 1995, 319(1):1-9.
11. Campolo J., et al. Blood glutathione as independent marker of lipid peroxidation in heart failure. Int J Cardiol 2007, 117(1):45-50.
12. Dekleva M., et al. Left ventricular diastolic dysfunction is related to oxidative stress and exercise capacity in hypertensive patients with preserved systolic function. Cardiology 2007, 108(1):62-70.
13. Sam F., et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 2005, 11(6):473-480.
14. Mulcahy R.T., et al. Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 1997, 272(11):7445-7454.
15. Myhrstad M.C., et al. Flavonoids increase the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytical subunit promoter. Free Radic Biol Med 2002, 32(5):386-393.
16. Gouedard C., Barouki R., Morel Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol 2004, 24(12):5209-5222.
17. Seymour E.M., et al. Moderate calorie restriction improves cardiac remodeling and diastolic dysfunction in the Dahl-SS rat. J Mol Cell Cardiol 2006, 41(4):661-668.
18. 2+/calmodulin-dependent protein kinase II in the murine heart. Biochim Biophys Acta 2006, 1763(11):1275-1281.
19. Seymour E.M., et al. Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor κB activity and cytokine expression in rats with diastolic dysfunction. Hypertension 2010, 55(5):1179-1185.
20. T Method. Methods 2001, 25(4):402-408.
21. Tarmonova L., Shutov A.M., Chernysheva E.V. Factors influencing left ventricular diastolic function in elderly patients with chronic heart failure. Klin Med (Mosk) 2007, 85(2):26-29.
22. Damy T., et al. Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities. PLoS One 2009, 4(3):e4871.
23. Robinson I., et al. Vitamin E in humans: an explanation of clinical trial failure. Endocr Pract 2006, 12(5):576-582.
24. de Lorgeril M., et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure. Eur J Heart Fail 2001, 3(6):661-669.
25. Witte K.K., Clark A.L. Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture?. Heart Fail Monit 2005, 4(4):123-129.
26. Moskaug J.O., et al. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr 2005, 81(1 Suppl):277S-283S.
27. Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab 2006, 7(1):67-81.
28. Moon Y.J., Wang X., Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006, 20(2):187-210.
29. Ramadoss P., Marcus C., Perdew G.H. Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol 2005, 1(1):9-21.
30. Vasquez A., et al. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc Toxicol 2003, 3(2):153-163.
31. Lund A.K., et al. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol Appl Pharmacol 2003, 193(2):177-187.
32. Van der Heiden E., et al. Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/synergic activities in human and rat reporter gene assays. Anal Chim Acta 2009, 637(1-2):337-345.
33. Amakura Y., et al. Influence of food polyphenols on aryl hydrocarbon receptor-signaling pathway estimated by in vitro bioassay. Phytochemistry 2008, 69(18):3117-3130.
34. Li L., et al. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 2009, 26(4):872-882.
35. Sugatani J., et al. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem Pharmacol 2004, 67(5):989-1000.
36. Ramadass P., et al. Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction, and AhR-DNA binding activity in vascular endothelial cells. Toxicol Sci 2003, 76(1):212-219.
37. Amakura Y., et al. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol Pharm Bull 2003, 26(4):532-539.
38. Andreadi C.K., et al. Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol 2006, 69(3):1033-1040.
39. Kluth D., et al. Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic Biol Med 2007, 42(3):315-325.
40. Rahman I., Biswas S.K., Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006, 72(11):1439-1452.
41. Liu Y.C., et al. Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile. Life Sci 2007, 80(15):1420-1430.
42. Eggler A.L., Gay K.A., Mesecar A.D. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 2008, 52(Suppl 1):S84-S94.
43. Lee-Hilz Y.Y., et al. Pro-oxidant activity of flavonoids induces EpRE-mediated gene expression. Chem Res Toxicol 2006, 19(11):1499-1505.
44. Surh Y.J., et al. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 2005, 135(12 Suppl):2993S-3001S.
45. Sekhar K.R., et al. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of γ-glutamylcysteine synthetase. Free Radic Biol Med 2002, 32(7):650-662.
46. Masella R., et al. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 2005, 16(10):577-586.
47. Toufektsian M.-C., et al. Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemia-reperfusion injury. J Nutr 2008, 138(4):747-752.
48. Gong P., Cederbaum A.I. Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 2006, 43(1):144-153.
49. Xu C., Li C.Y., Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 2005, 28(3):249-268.